GO-CAM August 23, 2017: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
mNo edit summary
 
(44 intermediate revisions by 2 users not shown)
Line 24: Line 24:


= Minutes =
= Minutes =
*On call: Chris, Harold, Kevin, Kimberly, Rob, Sabrina, Sage, Seth, Suzi
*On call: Chris, Harold, Karen, Kevin, Kimberly, Pascale, Paul T., Rob, Sabrina, Sage, Seth, Stacia, Suzi


== New Features ==
== New Noctua Features ==
*Curators can submit an issue to the github tracker from the Issues menu
**Model will be automatically referenced in the github ticket and the github ticket number will be listed in the models menu
*Simple annoton editor
**Curators are prompted to add an annoton, but can add distinct parts of the annoton, if needed
**Will be prompted to add evidence and a reference
***References are fairly neutral right now - can add PMIDs, GO_REFs - just need to have them be properly formatted (e.g., PMID:nnnnnnnn or GO_REF:nnnnnnnn)
**Save annoton button adds the annoton to the graphical view, but curators still need to add a title and save their models in the graph view
*ACTION: Curators need to test the editor and give feedback.


== Modeling in Noctua ==
*We discussed what the current modeling statements in Noctua actually mean
*For example, the model currently requires that a molecular_function is associated with a cellular component
*Is it possible to make a different type of statement in Noctua, or GO in general?
**For example, a TF is observed in the cytoplasm, but it does not execute its MF there
*Curators should read Paul T.'s [https://www.ncbi.nlm.nih.gov/pubmed/27812932 chapter about representation of function in the GO Handbook]
*Can different localizations be annotated using different CC qualifiers?
*Counter-argument
**Shouldn't GO just be focused on capturing where activities occur?
**Adding more relations to CC could potentially generate another point for annotation inconsistency and noise
*One question: when would curators make an annotation to a CC and when not?
**If you don't know anything about a protein but its localization, curators would typically make that CC
*There is a distinction between saying a protein localizes to a CC and likely functions there vs a protein localizes to a CC and we don't know if it actually has a function there
*This is a very fundamental question for GO - what information do we want to capture and why?
**There are fundamental differences between the annotations that might result, say, from an HTP localization screen vs a well-studied gene for which we know exactly where and how it functions
*Should we use different qualifiers for CC?
*Should the GO supply different files with different qualifiers for our users?
*In terms of Noctua, what should the behavior be for simply adding a conventional CC annotation?
*ACTION ITEM: Draft different proposals for how to handle GO annotation statements going forward
**Annotation of well-studied genes vs annotation of isolated observations and GO-CAM models vs conventional annotation
**These proposals should be in place by the October GO meeting so we can discuss and make a decision
**Stakeholders and considerations:
***Developers
****Tool development and maintenance
*****Changes to existing UI
****Impacts on data storage
****Impacts on annotation file generation
****Impacts on data display
***Curators
****Efficiency of annotation
*****Capturing all data when reading a paper vs capturing only a defined subset of data
****Consistency of annotation
*****Adding more relations increases the number of decision points during curation which could lead to more inconsistency, and could, at least temporarily, reduce efficiency
****Dealing with legacy annotation
*****Individual groups could decide what is best for their annotation set
****Need for clear curation guidelines
***Users
****Clarity in semantics of GO annotation
*****Precision of results in building genes sets (eliminating false positive and false negatives)
*****Informativeness of enrichment results and other summary analyses
****Ease of use of GO data, i.e. would GO users effectively use different slices of GO annotation
****Opportunities to use GO for different types of analyses
****Communication and outreach if changes are made to current practice
== Different annotation scenarios for Cellular Component ==
**DPY-19 mannosyltransferase
***endoplasmic reticulum - functional
**ENU-3.6 - novel
***cytoplasm - functional?? (not known, but no compelling reason to think it's not)
**DAF-16 Forkhead TF
***cytoplasm - sequestered, not functional
***nucleus - functional
**WNT3a - receptor agonist activity
***endoplasmic reticulum lumen - trafficking, not functional
***extracellular exosome - functional
**HIST2H2AC - this is actually manually annotated to root MF, but has IBA and IEA for DNA binding
***nucleus - functional
***extracellular exosome - functional?? (not known, but no compelling reason to think it is)
**NRAS - GTPase
***Golgi apparatus - functional and trafficking, depending on context
***membrane - functional
***extracellular exosome - functional?? (not known, no compelling reason for either functional or non-functional)


[[Category: Annotation Working Group]]
 
[[Category:GO-CAM]]

Latest revision as of 05:43, 16 April 2019

Zoom URL

https://stanford.zoom.us/j/679970729

Agenda

github Trackers

  • Clarification about which one(s) to use
    • noctua - client and middleware code
    • noctua-models - annotation (may be merged with go-annotation)
    • minerva

Table Editor Workbench

  • Chris and Seth will demo the new 'Simple annoton editor' workbench now available in Noctua
  • The table editor allows curators to add, and edit, simple annotons in a table format
  • Annotations entered in the table are automatically added to the Noctua graph editor

Annotation Provenance

  • Review of how attribution is assigned for Noctua annotations
    • de novo annotations
    • imported annotations using function and component companions

Annotating with any UniProtID

  • Use add individual functionality

Minutes

  • On call: Chris, Harold, Karen, Kevin, Kimberly, Pascale, Paul T., Rob, Sabrina, Sage, Seth, Stacia, Suzi

New Noctua Features

  • Curators can submit an issue to the github tracker from the Issues menu
    • Model will be automatically referenced in the github ticket and the github ticket number will be listed in the models menu
  • Simple annoton editor
    • Curators are prompted to add an annoton, but can add distinct parts of the annoton, if needed
    • Will be prompted to add evidence and a reference
      • References are fairly neutral right now - can add PMIDs, GO_REFs - just need to have them be properly formatted (e.g., PMID:nnnnnnnn or GO_REF:nnnnnnnn)
    • Save annoton button adds the annoton to the graphical view, but curators still need to add a title and save their models in the graph view
  • ACTION: Curators need to test the editor and give feedback.

Modeling in Noctua

  • We discussed what the current modeling statements in Noctua actually mean
  • For example, the model currently requires that a molecular_function is associated with a cellular component
  • Is it possible to make a different type of statement in Noctua, or GO in general?
    • For example, a TF is observed in the cytoplasm, but it does not execute its MF there
  • Curators should read Paul T.'s chapter about representation of function in the GO Handbook
  • Can different localizations be annotated using different CC qualifiers?
  • Counter-argument
    • Shouldn't GO just be focused on capturing where activities occur?
    • Adding more relations to CC could potentially generate another point for annotation inconsistency and noise
  • One question: when would curators make an annotation to a CC and when not?
    • If you don't know anything about a protein but its localization, curators would typically make that CC
  • There is a distinction between saying a protein localizes to a CC and likely functions there vs a protein localizes to a CC and we don't know if it actually has a function there
  • This is a very fundamental question for GO - what information do we want to capture and why?
    • There are fundamental differences between the annotations that might result, say, from an HTP localization screen vs a well-studied gene for which we know exactly where and how it functions
  • Should we use different qualifiers for CC?
  • Should the GO supply different files with different qualifiers for our users?
  • In terms of Noctua, what should the behavior be for simply adding a conventional CC annotation?
  • ACTION ITEM: Draft different proposals for how to handle GO annotation statements going forward
    • Annotation of well-studied genes vs annotation of isolated observations and GO-CAM models vs conventional annotation
    • These proposals should be in place by the October GO meeting so we can discuss and make a decision
    • Stakeholders and considerations:
      • Developers
        • Tool development and maintenance
          • Changes to existing UI
        • Impacts on data storage
        • Impacts on annotation file generation
        • Impacts on data display
      • Curators
        • Efficiency of annotation
          • Capturing all data when reading a paper vs capturing only a defined subset of data
        • Consistency of annotation
          • Adding more relations increases the number of decision points during curation which could lead to more inconsistency, and could, at least temporarily, reduce efficiency
        • Dealing with legacy annotation
          • Individual groups could decide what is best for their annotation set
        • Need for clear curation guidelines
      • Users
        • Clarity in semantics of GO annotation
          • Precision of results in building genes sets (eliminating false positive and false negatives)
          • Informativeness of enrichment results and other summary analyses
        • Ease of use of GO data, i.e. would GO users effectively use different slices of GO annotation
        • Opportunities to use GO for different types of analyses
        • Communication and outreach if changes are made to current practice

Different annotation scenarios for Cellular Component

    • DPY-19 mannosyltransferase
      • endoplasmic reticulum - functional
    • ENU-3.6 - novel
      • cytoplasm - functional?? (not known, but no compelling reason to think it's not)
    • DAF-16 Forkhead TF
      • cytoplasm - sequestered, not functional
      • nucleus - functional
    • WNT3a - receptor agonist activity
      • endoplasmic reticulum lumen - trafficking, not functional
      • extracellular exosome - functional
    • HIST2H2AC - this is actually manually annotated to root MF, but has IBA and IEA for DNA binding
      • nucleus - functional
      • extracellular exosome - functional?? (not known, but no compelling reason to think it is)
    • NRAS - GTPase
      • Golgi apparatus - functional and trafficking, depending on context
      • membrane - functional
      • extracellular exosome - functional?? (not known, no compelling reason for either functional or non-functional)